8 completed, 7 unknown, 5 recruiting, 2 terminated. 24 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 24 | Completed 8, Unknown 7, Recruiting 5, Terminated 2, Active not recruiting 1, Withdrawn 1 |
Follow Positron-Emission Tomography: new trials by email Literature Review of Positron-Emission Tomography trials Research Report on Positron-Emission Tomography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer standard-of-care imaging (18F-FDG PET/CT), 68Ga-MY6349 PET/CT - Tumor, Solid Tumor | Not applicable | Terminated | The First Affiliated Hospital of Xiamen University | 149 | 2024-06-13 | 2026-05-28 |
| Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer [68Ga]Ga-NOTA-WWH347 or [18F]F-H3RESCA-WWH347 - Positron-Emission Tomography, Colorectal Neoplasms | Not applicable | Unknown | Huashan Hospital | 40 | 2023-12-01 | 2024-02-20 |
| Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors [68Ga]Ga-NOTA-T4 or [18F]AlF-RESCA-T4 - Positron-Emission Tomography, Neoplasms | Not applicable | Unknown | Huashan Hospital | 60 | 2023-12-01 | 2024-06-18 |
| ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Solid Tumors standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT - Tumor, Solid Tumor | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 90 | 2023-10-01 | 2024-12-18 |
| The Role of Imaging in the Diagnosis, Management and Prognosis of Possible Non-convulsive Status Epilepticus MRI scan including arterial spin labelling of the brain, CT perfusion scan of the brain, FDG-PET scan of the brain - Status Epilepticus, Ictal-interictal Continuum | Not applicable | Recruiting | Universitaire Ziekenhuizen KU Leuven | 200 | 2023-10-01 | 2024-12-27 |
| 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG 18F-FDG PET/CT, 68Ga-FAPI-LM3 PET/CT - SSTR2, FAP | Not applicable | Recruiting | The First Affiliated Hospital of Xiamen University | 30 | 2023-04-09 | 2025-08-08 |
| 68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT - Tumor, Solid, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 27 | 2022-07-01 | 2023-02-27 |
| FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application 68Ga-Fibroblast activation protein inhibitor - Malignant Tumors, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Anhui Medical University | 22 | 2022-04-28 | 2025-08-13 |
| Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer 18F-FDG - Tumor, Solid, Positron-Emission Tomography | Not applicable | Completed | The First Affiliated Hospital of Xiamen University | 67 | 2022-03-01 | 2023-02-27 |
| Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer stereotactic body radiotherapy, androgen deprivation therapy, Radiotherapy - Prostate Cancer Metastatic, Radiation Therapy | Not applicable | Recruiting | Karin Soderkvist | 118 | 2021-10-27 | 2026-02-17 |
| Application of 68Ga-Pentixafor PET/CT in Primary Aldosteronism and Pre-postoperative of SAAE 68Ga-Pentixafor - Positron-Emission Tomography | Not applicable | Recruiting | First Affiliated Hospital of Fujian Medical University | 100 | 2020-09-01 | 2026-07-21 |
| Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma uEXPLORER/mCT, mCT/uEXPLORER - Lung Neoplasm, Lymphoma | Not applicable | Active not recruiting | University of California, Davis | 180 | 2020-06-01 | 2026-07-06 |
| Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma 18F-FDG and 68Ga-NOTA-FAPI04 PET/CT, 18F-FDG and 18F-NOTA-FAPI04 PET/CT - Tumor, Solid, Positron-Emission Tomography | Not applicable | Unknown | Peking University Cancer Hospital & Institute | 200 | 2020-05-01 | 2020-04-29 |
| Dynamic FDG PET/CT: Optimization and Validation of Data Acquisition Dynamic Whole-Body parametric PET/CT - Positron-Emission Tomography | Not applicable | Completed | Aarhus University Hospital | 20 | 2020-01-01 | 2022-02-22 |
| Comparison of FDG and FAPI in Patients With Various Types of Cancer 18F-FDG and 68Ga-DOTA-FAPI -04 PET/CT - Tumor, Solid, Positron-Emission Tomography | Not applicable | Recruiting | The First Affiliated Hospital of Xiamen University | 3000 | 2019-10-20 | 2023-08-08 |
| Positron Nuclide Labeled DOTA-FAPI PET Study in Colocrectal Cancer 18F-FDG and 68Ga-DOTA-FAPI04 PET/CT, 18F-FDG and 18F-DOTA-FAPI04 PET/CT - Tumor, Solid, Positron-Emission Tomography | Not applicable | Unknown | Peking University Cancer Hospital & Institute | 60 | 2019-10-16 | 2022-06-27 |
| Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. <Sup>18<Sup>F-FDG PET/CT dynamic scan, B-ultrasonography - Positron-Emission Tomography, Lymph Node Metastases | Not applicable | Unknown | Fifth Affiliated Hospital, Sun Yat-Sen University | 50 | 2018-11-01 | 2022-07-28 |
| Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma PET/CT dynamic scan - Positron-Emission Tomography, Carcinoma, Hepatocellular | Not applicable | Withdrawn | Fifth Affiliated Hospital, Sun Yat-Sen University | 2018-06-13 | 2025-03-24 | |
| FCH PET/MRI Parathyroid Localization [F-18]-FCH PET/MRI - 18F-fluorocholine, Positron-Emission Tomography | Not applicable | Completed | University Health Network, Toronto | 47 | 2018-04-03 | 2023-12-07 |
| Validation of PET-MRI for Cardiovascular Disease PET/MR scan - MRI, PET Scan | Not applicable | Completed | University of Edinburgh | 20 | 2017-02-09 | 2024-05-21 |
Showing 20 of 24. Sign in to see all of them.
Neoplasms (9) · Disease (6) · Colorectal Neoplasms (2) · Lymphoma (2) · Thyroid Neoplasms (2) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Hyperparathyroidism, Primary (1) · Lung Neoplasms (1) · Lymphatic Metastasis (1) · Melanoma (1) · Neoplasm Metastasis (1)
Neoplasms by Site (9) · Pathological Conditions, Signs and Symptoms (8) · Neoplasms (7) · Pathologic Processes (7) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms by Histologic Type (3) · Colonic Diseases (2) · Endocrine Gland Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2)
Androgen Antagonists (1) · Biopsy (1) · Cerebrovascular Circulation (1) · Gonadotropin-Releasing Hormone (1) · Immunization (1) · Multiparametric Magnetic Resonance Imaging (1) · Positron Emission Tomography Computed Tomography (1) · Positron-Emission Tomography (1) · Radiosurgery (1) · Radiotherapy (1) · Radiotherapy, Image-Guided (1)
The First Affiliated Hospital of Xiamen University (6) · Fifth Affiliated Hospital, Sun Yat-Sen University (2) · Huashan Hospital (2) · Peking University Cancer Hospital & Institute (2) · Aarhus University Hospital (1) · Copenhagen University Hospital, Rigshospitalet (1) · First Affiliated Hospital of Fujian Medical University (1) · Imperial College London (1) · Istituto Clinico Humanitas (1) · Karin Soderkvist (1) · Lille Catholic University (1) · The First Affiliated Hospital of Anhui Medical University (1) · Universitaire Ziekenhuizen KU Leuven (1) · University Health Network, Toronto (1) · University of California, Davis (1)
China (14) · Denmark (2) · Belgium (1) · Canada (1) · Italy (1) · Sweden (1) · United Kingdom (1) · United States (1)
Long Sun, PhD (3) · Fang Xie, PhD (2) · David JM Lewis, MD (1) · Egesta Lopci (1) · Huiqin Xu (1) · Jean Louis Bonnal, MD (1) · Liangdi Xie, MD (1) · Lisbeth Marner, MD PhD DMSc (1) · Lorenzo Nardo, MD (1) · Wim Van Paesschen, MD PhD (1) · Zhi Yang (1) · Zhi Yang, PhD (1)
PMID 10749239, PMID 12183436, PMID 12542520, PMID 14602860, PMID 15767544, PMID 16549957, PMID 17363526, PMID 17575208, PMID 18570153, PMID 19721715, PMID 19817894, PMID 19872213, PMID 22236832, PMID 22371645, PMID 22614695, PMID 25143865, PMID 29496096, PMID 29626119, PMID 30072500, PMID 30850501, PMID 31631858, PMID 31912902, PMID 32222810, PMID 32632460, PMID 33179149, PMID 33778675, PMID 34581274, PMID 37385675, PMID 37601238, PMID 38176714, PMID 39509246, PMID 41882599, PMID 42180616, PMID 9065413